Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines
Top Cited Papers
- 30 April 2003
- journal article
- review article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 39 (6), 718-727
- https://doi.org/10.1016/s0959-8049(02)00811-0
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ studyBritish Journal of Cancer, 2001
- Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon CancerThe New England Journal of Medicine, 2001
- Current treatment for colorectal cancer metastatic to the liverEuropean Journal of Surgical Oncology, 1999
- The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissuesSeminars in Cancer Biology, 1999
- Role of follow-up in management of local recurrences of colorectal cancerDiseases of the Colon & Rectum, 1998
- Preoperative Carcinoembryonic Antigen Predicts Outcomes in Node-Negative Colon Cancer Patients: A Multivariate Analysis of 572 PatientsJournal of the American College of Surgeons, 1997
- Differences in serum tumor markers between colon and rectal cancerDiseases of the Colon & Rectum, 1996
- Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancerEuropean Journal of Cancer, 1996
- Pre- and Postoperative Carcinoembryonic Antigen Determinations in Hepatic Resection for Colorectal Metastases Predictive Value and Implications for Adjuvant Treatment Based on Multivariate AnalysisAnnals of Surgery, 1994
- Assessment of serial carcinoembryonic antigen: Determinations to monitor the therapeutic progress and prognosis of metastatic liver disease treated by regional chemotherapyJournal of Surgical Oncology, 1989